Anteris Technologies up as brokerages initiate coverage post-research quiet period

Anteris Technologies Global

07/01/2025 15:10

** Shares of heart valve maker Anteris Technologies  AVR.O 
rise as much as 6.8%; last up 4.2% at $5.84 in early trading
    ** Wall Street brokerages start coverage of AVR as IPO
research quiet period comes to an end
    ** Barclays initiates coverage with "overweight" rating and
$22 PT, a 292.2% upside to stock's last close
    ** Brokerage says AVR's transcatheter aortic valve
replacement (TAVR) platform is positioned to capture 4%-5% of
the U.S. TAVR market
    ** Adds that the timing for AVR's entry into TAVR could not
look better
    ** TD Cowen initiates coverage with "buy" rating and $15 PT,
a 167.4% upside to stock's last close
    ** Brokerage says AVR's TAVR platform has disruptive
potential that fills unmet needs in the industry
    ** Adds that AVR should capture meaningful share in the ~$10
bln TAVR market
    ** TD Cowen, Barclays and Cantor were the joint book-running
managers for AVR's IPO
    ** As of last close, AVR shares down 6.5% since Nasdaq debut
on Dec. 13

 (Reporting by Arasu Kannagi Basil in Bengaluru)
 ((ArasuKannagi.Basil@thomsonreuters.com;))